In this monthly roundup, consumer safety is under renewed scrutiny across the beauty and personal care industry, with recalls, regulatory warnings and advertising rulings highlighting the responsibilities facing manufacturers and retailers. From bacterial contamination and hazardous ingredients to sunscreen labelling and unsubstantiated efficacy claims, regulators are increasingly focused not only on what products contain, but on how they are manufactured, packaged and marketed.
Product recalls remain one of the most immediate challenges. Henkel recalled Schwarzkopf Professional Osis Grip over a packaging-related risk, demonstrating that consumer safety extends beyond formulation to the functionality and integrity of the finished pack. The company also recalled Tec Italy shampoo following concerns over bacterial contamination, placing manufacturing and quality control firmly in focus.
Microbiological contamination is affecting other major businesses. Kao USA recalled select lots of Oribe shampoo over potential bacterial contamination, while Target recalled its Up & Up baby wipes for a similar reason. The incidents underline the importance of robust microbiological testing and quality assurance, particularly for products used regularly or by potentially more vulnerable consumers.
Ingredient safety is also driving regulatory action. Morovan nail polish remover was recalled over hazardous ingredients, reinforcing the need for brands and suppliers to maintain rigorous oversight of formulations and ensure products comply with applicable safety requirements throughout their lifecycle.
Sun protection continues to attract particularly close scrutiny. The Australian Competition and Consumer Commission (ACCC) is reviewing the labelling of Woolworths ‘Kids’ sunscreen following a complaint concerning a controversial UV filter. The development comes amid heightened attention around sunscreen performance and formulation in Australia, where consumer confidence in SPF products has become an increasingly important regulatory issue.
Advertising claims are facing similar examination. The UK’s Advertising Standards Authority (ASA) banned a claim for a Beauty Pie LED mask after finding insufficient clinical evidence to substantiate it. As beauty devices increasingly make claims that sit between cosmetics, wellness and medical benefits, companies face a growing burden to ensure marketing language is supported by appropriate evidence.
In the US, the FDA warned Revlon over product safety testing and quality control failures, highlighting the consequences of weaknesses in manufacturing and compliance systems. For established global brands as much as emerging businesses, regulatory expectations around documentation, testing and quality assurance are becoming increasingly difficult to separate from wider brand reputation.
Children’s relationship with beauty is emerging as another major consumer safety issue. Concerns over ‘cosmeticorexia’—the growing obsession with skincare and cosmetic routines among young girls—are intensifying debate around age-appropriate products and marketing. Sephora is responding by introducing safeguards around the marketing of anti-ageing skincare to children, signalling that retailers may increasingly be expected to take responsibility for how adult-oriented beauty categories are presented to younger consumers.
Taken together, this monthly roundup demonstrates that consumer safety now extends far beyond traditional ingredient compliance. Manufacturing standards, contamination controls, packaging, clinical substantiation, advertising and age-appropriate marketing are all becoming part of the same conversation. In 2026, maintaining consumer trust will depend not simply on responding quickly when problems emerge, but on embedding safety, evidence and accountability throughout the entire product lifecycle.
